Figure 1 displays adjusted odds ratios (ORs) and probabilities for seizure response at 6 months. Graph A shows ORs comparing antiseizure meds; graph B shows model-adjusted probabilities for each medication: Cenobamate, Lacosamide, Perampanel, Brivaracetam.
In adults with drug-resistant #FocalEpilepsy, cenobamate was associated with greater seizure reduction and seizure freedom vs brivaracetam, lacosamide, and perampanel, but with more adverse effects.
ja.ma/3ZE7zAN